IRIS
GABRIELLI, Armando
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.320
EU - Europa 5.943
AS - Asia 2.164
AF - Africa 173
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
SA - Sud America 3
Totale 18.624
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.289
UA - Ucraina 1.349
IT - Italia 1.028
SE - Svezia 883
IE - Irlanda 743
DE - Germania 649
SG - Singapore 642
CN - Cina 475
DK - Danimarca 464
TR - Turchia 458
FI - Finlandia 278
HK - Hong Kong 273
KR - Corea 243
FR - Francia 233
GB - Regno Unito 192
CI - Costa d'Avorio 105
MA - Marocco 66
IN - India 46
BE - Belgio 39
CA - Canada 29
PL - Polonia 21
NL - Olanda 16
RU - Federazione Russa 16
EU - Europa 14
RS - Serbia 10
JP - Giappone 9
VN - Vietnam 6
AU - Australia 5
ES - Italia 5
RO - Romania 4
AT - Austria 3
CH - Svizzera 3
AL - Albania 2
BR - Brasile 2
EG - Egitto 2
IR - Iran 2
MX - Messico 2
NZ - Nuova Zelanda 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CL - Cile 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
PT - Portogallo 1
Totale 18.624
Salva come PNG Salva come JPEG
Città #
Chandler 1.457
Jacksonville 1.410
Fairfield 839
Dublin 741
Boardman 685
Ashburn 632
Wilmington 546
Woodbridge 392
Houston 356
New York 333
Seattle 332
Centro 325
Des Moines 319
Singapore 300
Lawrence 296
Princeton 296
San Mateo 295
Hong Kong 269
Cambridge 231
Ann Arbor 225
San Diego 111
Abidjan 105
Beijing 104
Turin 68
Helsinki 56
Los Angeles 44
Pune 44
London 42
Guangzhou 38
Redmond 37
Washington 37
Brussels 36
Marche 35
Munich 35
Ancona 33
Shanghai 31
Norwalk 28
Dallas 27
Jesi 22
Wuhan 22
Porto 20
Jiaxing 19
Milan 19
Auburn Hills 18
Falls Church 16
Izmir 15
Ottawa 14
Kilburn 12
Rome 12
Castelfidardo 11
Belgrade 10
Iesi 10
Jinhua 10
Shenzhen 10
Bologna 8
Yiwu 8
New Bedfont 7
Southwark 7
Tolentino 7
Brescia 6
Dong Ket 6
Hanover 6
Monte San Pietrangeli 6
Montréal 6
Ostra 6
San Giorgio A Cremano 6
Santa Clara 6
Wuxi 6
Brisbane 5
Civitanova Marche 5
Comunanza 5
Florence 5
Nanjing 5
Nürnberg 5
Prescot 5
Quanzhou 5
San Benedetto Del Tronto 5
Sassoferrato 5
Seoul 5
Squinzano 5
Taranto 5
Torre Annunziata 5
Amandola 4
Chiaravalle 4
Macerata 4
Montemarciano 4
Toronto 4
Atella 3
Bucharest 3
Camerino 3
Chicago 3
Corridonia 3
Falconara Marittima 3
Fayetteville 3
Foggia 3
Frankfurt am Main 3
Kraków 3
Leawood 3
Nizhniy Novgorod 3
Osimo 3
Totale 11.650
Salva come PNG Salva come JPEG
Nome #
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease 127
null 125
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 124
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 120
La terapia con immunoglobuline endovena nelle malattie autoimmuni 112
Erratum: Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance [Radiol med, DOI 10.1007/s11547-014-0419-7] 106
Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis 106
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies 104
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 100
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-associated spondyloarthritis. 100
null 100
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 100
Computed tomography assessment of evolution of interstitial lung disease in systemic sclerosis: Comparison of two scoring systems 99
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 99
Cardiac involvement in polymyositis and dermatomyositis 98
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 97
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 96
Cognitive and cerebral hemodynamic impairment in scleroderma patients 95
Adalimumab modulates angiogenesis in psoriatic skin 94
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 93
Certolizumab pegol for the treatment of psoriasis 93
Piascledine modullates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes 92
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 92
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 91
Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs 90
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 90
Subcutaneous IgG in the Myositis Spectrum Disorders 89
c-myb but not B-myb upregulates a1(I) and a2(I) collagen genes in fibroblasts 88
AIRE gene polymorphisms in Systemic Sclerosis associated with autoimmune thyroiditis 88
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 88
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 88
Identification of a novel human DRB1*13 allele by sequence-based DRB typing. 87
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 87
Aseptic inflammation of prosthetic knee in a patient affected by rheumatoid arthritis 87
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 87
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 87
Successful treatment of a Caucasian case of multifocal Castleman¿s disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report 86
Systemic sclerosis (scleroderma) and cancer risk: Systematic review and meta-analysis of observational studies 86
Assessment of gastrointestinal involvement in scleroderma. 85
A randomized controlled trial of Rituximab for the treatment of severe cryoglobulinemic vasculitis. 85
Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study. 84
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 84
c-myb proto-oncogene is expressed by quiescent fibroblasts and unlike B-myb gene does not correlate with proliferation 83
Pathogenic autoantibodies in systemic sclerosis 82
Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts. 82
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 81
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 81
Biosensor-based Binding Assay for Platelet-Derived Growth Factor Receptor-α Autoantibodies in Human Serum 81
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 81
The DETection of Arthritis in Inflammatory boweL diseases (DETAIL) questionnaire: development and preliminary testing of a new tool to screen patients with inflammatory bowel disease for the presence of spondyloarthritis 81
Chronic hepatitis E in a patient treated with rituximab and mycophenolate mofetil for Sjögren's syndrome 81
Scleroderma. 80
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 80
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 80
Clinical and patient reported outcomes of the multidisciplinary management in patients with inflammatory bowel disease-associated spondyloarthritis 80
Effect of Adalimumab Therapy on Both Gastrointestinal and Articular Inflammation at 6 Months in Patients Affected by Enteropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 80
Osservazione di una nuova mutazione puntiforme del gene p53 nel seminoma tipico del testicolo: descrizione di un caso 79
c-MYB transactivates the alpha 2(I) collagen gene. 79
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 78
The risk of non-Hodgkin's lymphoma in coeliac disease: a case-control, multicentre study 78
Patient Reported Outcomes and Quality of Life in a Cohort of Patients Affected by Entheropathic Spondyloarthritis: Preliminary Results from a Monocentric Prospective Observational Study 78
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 77
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 77
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 77
Reduction of bcl-2 in T-cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erithematosus 76
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 76
BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED ARTHRITIS: SAFETY PROFILE 76
Biologics in inflammatory and immunomediated arthritis 76
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 76
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 76
Low-dose Oral Imatinib in the treatment of systemic sclerosis interstitial lung disease unresponsive to cyclophosphamide. A phase II pilot study 76
Recommendations for the management of biofilm: a consensus document. 76
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis c virus infection? 75
TOSSE STIZZOSA: PRESENTAZIONE ATIPICA DI UNA VASCULITE DEI GRANDI VASI 75
Traiano: Educational (but not only) opportunity for Master Students 75
Mapping and predicting mortality from systemic sclerosis 75
Deflazacort moduletes the fibrynolitic pattern and reduces uPA-dependent chemoinvasion and proliferation in rheumatoid arthritis synoviocytes 74
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 74
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway 74
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 74
Detection of typical and atypical bovine spongiform encephalopathy and scrapie prion strains by prion protein motif-grafted antibodies. 74
A novel HLA-Cw*6 allele Cw*160102, identified by cloning and sequencing. 73
Biologics in inflammatory immune-mediated systemic diseases 73
A painful diagnosis 73
Immunohistochemical localization of intracellular and extracellular associated TGFb in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon 72
Risk of non-Hodgkin lymphoma in celiac disease 72
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 72
SpA and PsA basic and translational research OP0205 Gut Dysbiosis in Patients with HLA-B27+ Ankylosing Spondylitis is Associated with Ileitis, Down-Regulation of Tight Junction Proteins, Increased Serum Levels of LPS and Monocytes Anergy 72
Myocardial perfusion defects in scleroderma detected by contrast-enhanced cardiovascular magnetic resonance 72
Acute myocarditis associated with adenoviral infection in a patient with scleroderma 72
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 72
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 71
Bone marrow endothelial progenitors are defective in systemic sclerosis 71
Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis 71
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 71
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 71
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 71
Sustained clinical response after single course of rituximab as first-line monotherapy in adult-onset asthma and periocular xanthogranulomas syndrome associated with IgG4-related disease: A case report 71
History and scientific production of clinica medica and clinica ematologica in ancona 71
Dynamics of hepatitis C virus viremia after perturbation by plasma exchange 70
Totale 8.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.492
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.116 0 0 0 0 0 0 295 34 297 28 86 376
2020/20213.944 192 418 555 41 516 195 373 230 434 339 437 214
2021/20222.116 109 538 64 131 19 109 78 161 126 132 202 447
2022/20234.203 381 436 344 356 307 704 13 281 1.014 38 219 110
2023/20242.265 420 47 136 345 363 498 37 57 13 69 21 259
2024/20251.750 440 435 197 47 209 125 297 0 0 0 0 0
Totale 19.031